• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TTB
Click for more information
0.00% 26.0¢

TOTAL BRAIN LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
TTB AGM Results27/11/14
TTB AGM Chairmans address for todays meeting27/11/14
TTB BRC to partner with NRMAPRICE SENSITIVE26/11/14
TTB Notice of Annual General Meeting/Proxy Form24/10/14
TTB Appendix 4C - quarterlyPRICE SENSITIVE23/10/14
TTB Change of Director's Interest Notice NDH15/10/14
TTB Quarterly Activities ReportPRICE SENSITIVE13/10/14
TTB Updated Shareholder and Option Holder Information03/10/14
TTB Corporate Governance Review03/10/14
TTB Change of Director's Interest Notice EG DS NH01/10/14
TTB Appendix 3B SPP22/09/14
TTB Top 20 shareholders following placement28/08/14
TTB Change in substantial holding27/08/14
TTB Placement of Shares and Appendix 3B26/08/14
TTB Presentations by sales team22/08/14
TTB Share Purchase PlanPRICE SENSITIVE22/08/14
TTB Annual Report to shareholders21/08/14
TTB Appendix 4EPRICE SENSITIVE21/08/14
TTB BRC expands US Addiction clinic salesPRICE SENSITIVE20/08/14
TTB Results of Meeting19/08/14
TTB Appendix 4C June 2014PRICE SENSITIVE25/07/14
TTB Notice of Extraordinary General Meeting/Proxy Form15/07/14
TTB Change of Director's Interest Notice11/07/14
TTB Updated investor presentation09/07/14
TTB $7 million capital raisingPRICE SENSITIVE04/07/14
TTB Trading HaltPRICE SENSITIVE02/07/14
TTB ADHD Treatment Scientific Publication26/06/14
TTB Director Resignation and Appendix 3Z23/06/14
TTBFirst Scientific Publication of Treatment Prediction iSPOT19/05/14
TTBAppendix 4C - quarterlyPRICE SENSITIVE29/04/14
TTBOffice update and Appendix 3B31/03/14
TTBUpdated investor presentation12/03/14
TTBPartner product launches that include BRC content11/03/14
TTBHalf Year AccountsPRICE SENSITIVE24/02/14
TTBFDA UpdatePRICE SENSITIVE17/02/14
TTBAppendix 4C - quarterly December 2013PRICE SENSITIVE30/01/14
TTBConference and FDA update09/12/13
TTBResults of Meeting27/11/13
TTBChairman's Address to Shareholders27/11/13
TTBQuarterly update of focus and outcomes06/11/13
TTBAppendix 4C - quarterly UpdatePRICE SENSITIVE24/10/13
TTBNotice of Annual General Meeting/Proxy Form24/10/13
TTBAnnual Report to shareholders27/08/13
TTBAppendix 4EPRICE SENSITIVE27/08/13
TTBBecoming a substantial holder19/08/13
TTBAppendix 3B15/08/13
TTB$2m PlacementPRICE SENSITIVE15/08/13
TTBAppendix 4C - quarterlyPRICE SENSITIVE26/07/13
TTBBRC FDA UpdatePRICE SENSITIVE23/07/13
TTBMyBrainSolutions - bLife Business Partnership14/05/13
TTBBrain Resource partnering with Mapmygenome in IndiaPRICE SENSITIVE03/05/13
TTBAppendix 4C - quarterlyPRICE SENSITIVE29/04/13
TTBDepression Treatment Test updatePRICE SENSITIVE01/03/13
TTBPlacement of Shares to funds managed by Och ZiffPRICE SENSITIVE01/03/13
TTBHalf Year AccountsPRICE SENSITIVE28/02/13
TTBMHNet Behavioral Health to offer Brain HealthPRICE SENSITIVE08/02/13
TTBPresentation at Personalized Medicine World Conference29/01/13
TTBAppendix 4C - quarterlyPRICE SENSITIVE22/01/13
TTBResults of Meeting21/11/12
TTBChairman's Address to Shareholders21/11/12
TTBAppendix 4C - quarterlyPRICE SENSITIVE29/10/12
TTBUpdate on FDA meeting22/10/12
TTBNotice of Annual General Meeting/Proxy Form22/10/12
TTBLaunch of ADHD PortalPRICE SENSITIVE10/10/12
TTBAppendix 4E and Financial ReportsPRICE SENSITIVE27/08/12
TTBAppendix 4C - quarterlyPRICE SENSITIVE26/07/12
TTBUpdated Investor Presentation09/07/12
TTBFDA meeting update03/07/12
TTBFDA response to Pre-IDE submission07/05/12
TTBAppendix 4C - quarterly March 2012PRICE SENSITIVE27/04/12
TTBUpdated Investor Presentation11/04/12
TTBChange in executive management structure15/03/12
TTBAetna begins selling MyBrainSolutions15/03/12
TTBHalf Year Report and AccountsPRICE SENSITIVE27/02/12
TTBAppendix 4C - quarterlyPRICE SENSITIVE30/01/12
TTBPersonalized Medicine World Conference Presentation24/01/12
TTBCeasing to be a substantial holder17/01/12
TTBAppendix 3B21/12/11
TTBNew ADHD venture fundedPRICE SENSITIVE14/12/11
TTBResults of Meeting30/11/11
TTBChairman's Address to Shareholders30/11/11
TTBConvertible Bond issue Appendix 3B08/11/11
TTBCleansing statement for convertible bond issue02/11/11
TTBSecond tranche of convertible bonds issued02/11/11
TTBNotice of Annual General Meeting/Proxy Form31/10/11
TTBNew ADHD VenturePRICE SENSITIVE31/10/11
TTBAppendix 4C - quarterlyPRICE SENSITIVE27/10/11
TTBChange of Director's Interest Notice - Revised29/09/11
TTBChange of Director's Interest Notice26/09/11
TTBInvestor newsletter02/09/11
TTBAnnual Report and Appendix 4EPRICE SENSITIVE18/08/11
TTBResults of Meeting04/08/11
TTBAppendix 4C - quarterlyPRICE SENSITIVE28/07/11
TTBNotice of Extraordinary General Meeting/Proxy Form01/07/11
TTBChange in substantial holding28/06/11
TTBBecoming a substantial holder16/06/11
TTBOch-Ziff managed funds acquire strategic position - App 3B15/06/11
TTBOch-Ziff acquires strategic position in Brain ResourcePRICE SENSITIVE14/06/11
TTBInvestor Newsletter Update May 201101/06/11
TTBBroker Presentation26/05/11
TTB AGM Results
27/11/14
TTB AGM Chairmans address for todays meeting
27/11/14
TTB BRC to partner with NRMA
26/11/14PRICE SENSITIVE
TTB Notice of Annual General Meeting/Proxy Form
24/10/14
TTB Appendix 4C - quarterly
23/10/14PRICE SENSITIVE
TTB Change of Director's Interest Notice NDH
15/10/14
TTB Quarterly Activities Report
13/10/14PRICE SENSITIVE
TTB Updated Shareholder and Option Holder Information
03/10/14
TTB Corporate Governance Review
03/10/14
TTB Change of Director's Interest Notice EG DS NH
01/10/14
TTB Appendix 3B SPP
22/09/14
TTB Top 20 shareholders following placement
28/08/14
TTB Change in substantial holding
27/08/14
TTB Placement of Shares and Appendix 3B
26/08/14
TTB Presentations by sales team
22/08/14
TTB Share Purchase Plan
22/08/14PRICE SENSITIVE
TTB Annual Report to shareholders
21/08/14
TTB Appendix 4E
21/08/14PRICE SENSITIVE
TTB BRC expands US Addiction clinic sales
20/08/14PRICE SENSITIVE
TTB Results of Meeting
19/08/14
TTB Appendix 4C June 2014
25/07/14PRICE SENSITIVE
TTB Notice of Extraordinary General Meeting/Proxy Form
15/07/14
TTB Change of Director's Interest Notice
11/07/14
TTB Updated investor presentation
09/07/14
TTB $7 million capital raising
04/07/14PRICE SENSITIVE
TTB Trading Halt
02/07/14PRICE SENSITIVE
TTB ADHD Treatment Scientific Publication
26/06/14
TTB Director Resignation and Appendix 3Z
23/06/14
TTBFirst Scientific Publication of Treatment Prediction iSPOT
19/05/14
TTBAppendix 4C - quarterly
29/04/14PRICE SENSITIVE
TTBOffice update and Appendix 3B
31/03/14
TTBUpdated investor presentation
12/03/14
TTBPartner product launches that include BRC content
11/03/14
TTBHalf Year Accounts
24/02/14PRICE SENSITIVE
TTBFDA Update
17/02/14PRICE SENSITIVE
TTBAppendix 4C - quarterly December 2013
30/01/14PRICE SENSITIVE
TTBConference and FDA update
09/12/13
TTBResults of Meeting
27/11/13
TTBChairman's Address to Shareholders
27/11/13
TTBQuarterly update of focus and outcomes
06/11/13
TTBAppendix 4C - quarterly Update
24/10/13PRICE SENSITIVE
TTBNotice of Annual General Meeting/Proxy Form
24/10/13
TTBAnnual Report to shareholders
27/08/13
TTBAppendix 4E
27/08/13PRICE SENSITIVE
TTBBecoming a substantial holder
19/08/13
TTBAppendix 3B
15/08/13
TTB$2m Placement
15/08/13PRICE SENSITIVE
TTBAppendix 4C - quarterly
26/07/13PRICE SENSITIVE
TTBBRC FDA Update
23/07/13PRICE SENSITIVE
TTBMyBrainSolutions - bLife Business Partnership
14/05/13
TTBBrain Resource partnering with Mapmygenome in India
03/05/13PRICE SENSITIVE
TTBAppendix 4C - quarterly
29/04/13PRICE SENSITIVE
TTBDepression Treatment Test update
01/03/13PRICE SENSITIVE
TTBPlacement of Shares to funds managed by Och Ziff
01/03/13PRICE SENSITIVE
TTBHalf Year Accounts
28/02/13PRICE SENSITIVE
TTBMHNet Behavioral Health to offer Brain Health
08/02/13PRICE SENSITIVE
TTBPresentation at Personalized Medicine World Conference
29/01/13
TTBAppendix 4C - quarterly
22/01/13PRICE SENSITIVE
TTBResults of Meeting
21/11/12
TTBChairman's Address to Shareholders
21/11/12
TTBAppendix 4C - quarterly
29/10/12PRICE SENSITIVE
TTBUpdate on FDA meeting
22/10/12
TTBNotice of Annual General Meeting/Proxy Form
22/10/12
TTBLaunch of ADHD Portal
10/10/12PRICE SENSITIVE
TTBAppendix 4E and Financial Reports
27/08/12PRICE SENSITIVE
TTBAppendix 4C - quarterly
26/07/12PRICE SENSITIVE
TTBUpdated Investor Presentation
09/07/12
TTBFDA meeting update
03/07/12
TTBFDA response to Pre-IDE submission
07/05/12
TTBAppendix 4C - quarterly March 2012
27/04/12PRICE SENSITIVE
TTBUpdated Investor Presentation
11/04/12
TTBChange in executive management structure
15/03/12
TTBAetna begins selling MyBrainSolutions
15/03/12
TTBHalf Year Report and Accounts
27/02/12PRICE SENSITIVE
TTBAppendix 4C - quarterly
30/01/12PRICE SENSITIVE
TTBPersonalized Medicine World Conference Presentation
24/01/12
TTBCeasing to be a substantial holder
17/01/12
TTBAppendix 3B
21/12/11
TTBNew ADHD venture funded
14/12/11PRICE SENSITIVE
TTBResults of Meeting
30/11/11
TTBChairman's Address to Shareholders
30/11/11
TTBConvertible Bond issue Appendix 3B
08/11/11
TTBCleansing statement for convertible bond issue
02/11/11
TTBSecond tranche of convertible bonds issued
02/11/11
TTBNotice of Annual General Meeting/Proxy Form
31/10/11
TTBNew ADHD Venture
31/10/11PRICE SENSITIVE
TTBAppendix 4C - quarterly
27/10/11PRICE SENSITIVE
TTBChange of Director's Interest Notice - Revised
29/09/11
TTBChange of Director's Interest Notice
26/09/11
TTBInvestor newsletter
02/09/11
TTBAnnual Report and Appendix 4E
18/08/11PRICE SENSITIVE
TTBResults of Meeting
04/08/11
TTBAppendix 4C - quarterly
28/07/11PRICE SENSITIVE
TTBNotice of Extraordinary General Meeting/Proxy Form
01/07/11
TTBChange in substantial holding
28/06/11
TTBBecoming a substantial holder
16/06/11
TTBOch-Ziff managed funds acquire strategic position - App 3B
15/06/11
TTBOch-Ziff acquires strategic position in Brain Resource
14/06/11PRICE SENSITIVE
TTBInvestor Newsletter Update May 2011
01/06/11
TTBBroker Presentation
26/05/11
refresh Created with Sketch. REFRESH
 

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip Wealth Within chief analyst Dale Gillham and senior analyst Fil Tortevski have tipped $4.68 billion garbage giant Cleanaway Waste Management Limited (ASX:CWY) as their Hotcopper Hot Stock tip of the week @ especially because it seems to be slowly building towards a euphoric run akin to its mid 20...
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.